In addition, dietary regimens and protocols to examine the role of iNOS in IR, obesity, and diabetes [25,27,29,33,50] were also different reporting either IR and dyslipidemia [16,31,32,33] or protection against IR as outcome [25,26,27,28,29,30]. This evidence concerns the gene NOS2 and obesity due to melanocortin 4 receptor deficiency.